RGNT
$3.37
Market ClosedAs of Mar 17, 7:57 PM UTC
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial Launch
Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) is one of the best up and coming penny stocks to buy. On February 4, Regentis Biomaterials appointed Ori Gon as Chief Financial Officer and Chief Business Officer to lead the company’s financial strategy and commercial development. Gon joined the regenerative medicine firm as its lead product, GelrinC, nears commercial launch […]
Sector Update: Health Care Stocks Slide Late Afternoon
Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health
Sector Update: Health Care Stocks Softer in Afternoon Trading
Health care stocks declined Thursday afternoon with the NYSE Health Care Index dropping 0.5% and the